REHOVOT, Israel, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN)) (TASE:EVGN), a leading biotechnology company developing novel products for life science markets through the use of a unique Computational Predictive Biology (CPB) platform ...
more»